bpc-157 ind status fda Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future Perspectives BPC-157 FDA Approval Status 2026:

This is an area of early research interest in longevity science, as maintaining genomic integrity may support overall cellular health and healthy aging pathways

And a 2025 systematic review specifically examined BPC-157 from an orthopedic sports medicine perspective, noting the peptide's potential for promoting healing in musculoskeletal injuries including fractures, tendon ruptures, and muscle injuries in preclinical models

While one trial did show VAX-D to be more effective than TENS, concerns about study design, limited generalizability, and safety risks have kept it from being widely accepted as a standard treatment (Aetna Clinical Policy Bulletins, 2025)

Penile sensory thresholds for warm and cold sensations significantly increased after non-nerve-sparing RP surgery but not after nerve-sparing RP surgery 37